JPMorgan Chase & Co. Buys 5,307 Shares of ASP Isotopes Inc. (NASDAQ:ASPI)

JPMorgan Chase & Co. boosted its stake in ASP Isotopes Inc. (NASDAQ:ASPI) by 31.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,196 shares of the company’s stock after purchasing an additional 5,307 shares during the quarter. JPMorgan Chase & Co.’s holdings in ASP Isotopes were worth $62,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the business. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new stake in shares of ASP Isotopes in the third quarter valued at approximately $6,249,000. Telemark Asset Management LLC purchased a new position in shares of ASP Isotopes in the third quarter worth approximately $4,726,000. Philadelphia Financial Management of San Francisco LLC raised its position in shares of ASP Isotopes by 158.3% during the third quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock valued at $2,757,000 after buying an additional 607,893 shares during the last quarter. GSA Capital Partners LLP increased its position in ASP Isotopes by 96.0% in the third quarter. GSA Capital Partners LLP now owns 770,989 shares of the company’s stock worth $2,143,000 after purchasing an additional 377,721 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in ASP Isotopes by 42.7% during the third quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock worth $3,110,000 after buying an additional 334,836 shares during the period. 16.80% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group reiterated a “buy” rating and issued a $4.50 target price on shares of ASP Isotopes in a report on Friday, October 18th.

ASP Isotopes Stock Performance

Shares of ASP Isotopes stock opened at $5.75 on Tuesday. The stock has a market capitalization of $410.49 million, a price-to-earnings ratio of -9.43 and a beta of 3.51. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. The business has a 50-day moving average of $5.12 and a 200 day moving average of $4.30. ASP Isotopes Inc. has a 12 month low of $1.86 and a 12 month high of $9.33.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.